Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0012 Transporter Info | ||||
| Gene Name | ABCC3 | ||||
| Transporter Name | Multidrug resistance-associated protein 3 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Sodium taurocholate Drug Info | ||||
| Xenobiotic Type | Drug in Phase 1/2 Trial | ||||
| MOA | Inhibition | ||||
| PubChem CID | 23666345 | ||||
| Docking Score | -11.609 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C26H44NNaO7S | ||||
| Molecular Weight | 537.7 | ||||
| Canonical SMILES |
C[C@H](CCC(=O)NCCS(=O)(=O)[O-])[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C.[Na+]
|
||||
| InChI |
InChI=1S/C26H45NO7S.Na/c1-15(4-7-23(31)27-10-11-35(32,33)34)18-5-6-19-24-20(14-22(30)26(18,19)3)25(2)9-8-17(28)12-16(25)13-21(24)29;/h15-22,24,28-30H,4-14H2,1-3H3,(H,27,31)(H,32,33,34);/q;+1/p-1/t15-,16+,17-,18-,19+,20+,21-,22+,24+,25+,26-;/m1./s1
|
||||
| InChIKey | JAJWGJBVLPIOOH-IZYKLYLVSA-M | ||||
| Xenobiotic Name | Cefadroxil Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 47965 | ||||
| Docking Score | -11.343 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C16H17N3O5S | ||||
| Molecular Weight | 363.4 | ||||
| Canonical SMILES |
CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)SC1)C(=O)O
|
||||
| InChI |
InChI=1S/C16H17N3O5S/c1-7-6-25-15-11(14(22)19(15)12(7)16(23)24)18-13(21)10(17)8-2-4-9(20)5-3-8/h2-5,10-11,15,20H,6,17H2,1H3,(H,18,21)(H,23,24)/t10-,11-,15-/m1/s1
|
||||
| InChIKey | BOEGTKLJZSQCCD-UEKVPHQBSA-N | ||||
| Pharmaceutical Properties | Xlogp | -2.1 | Rotatable Bond Count | 4 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 7 | ||
| Xenobiotic Name | Cefuroxime Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 5479529 | ||||
| Docking Score | -11.078 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C16H16N4O8S | ||||
| Molecular Weight | 424.4 | ||||
| Canonical SMILES |
CO/N=C(/C1=CC=CO1)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O
|
||||
| InChI |
InChI=1S/C16H16N4O8S/c1-26-19-9(8-3-2-4-27-8)12(21)18-10-13(22)20-11(15(23)24)7(5-28-16(17)25)6-29-14(10)20/h2-4,10,14H,5-6H2,1H3,(H2,17,25)(H,18,21)(H,23,24)/b19-9-/t10-,14-/m1/s1
|
||||
| InChIKey | JFPVXVDWJQMJEE-IZRZKJBUSA-N | ||||
| Pharmaceutical Properties | Xlogp | -0.2 | Rotatable Bond Count | 8 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 10 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.